Contract Development Services

Sitting Down With... Cornell Stamoran, Vice President of Corporate Strategy, Catalent Pharma Solutions, USA.

What does your product demand guesstimate look like, and how can you be sure things won’t suddenly change?

The US and and EU deadlines are approaching, but is the industry ready for serialization?

Scaling up a bioprocess doesn’t need to be a headache - especially when there are firms out there that can lend a helping hand

When making advanced medicines, the cost of manufacture must be lower than reimbursement

One of the biggest pharma trade shows in Europe kicks off at the end of October

Each new drug is unique and deserves a fresh approach to formulation.

Patheon's Steve Lam shares his lessons learned over three decades in bioprocessing.

What do trends in small molecule drugs mean for contract manufacturers?

Sitting Down With... Ian Muir, Managing Director, Aesica, UK.